| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/02/2006 | WO2005085861A3 Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer |
| 02/02/2006 | WO2005067543A3 Murine calicivirus |
| 02/02/2006 | WO2005066207A8 Glucagon-like peptide-1 analogs with long duration of action |
| 02/02/2006 | WO2005051996A3 Protein from horn fly saliva that disrupts hemostasis |
| 02/02/2006 | WO2005046577A3 Human prostaglandin ep1 receptor variants and methods of using same |
| 02/02/2006 | WO2005016130A3 Recombinant lubricin molecules and uses thereof |
| 02/02/2006 | WO2004113503A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 02/02/2006 | WO2004100877A3 Vaccine accelerator factor (vaf) for poultry |
| 02/02/2006 | WO2003102166A3 Novel flavivirus antigens |
| 02/02/2006 | WO2003093298A3 Immunogenic peptides |
| 02/02/2006 | WO2003035006A3 Amyloid ss is a ligand for fpr class receptors |
| 02/02/2006 | WO2002101071A3 Cd43:modulators of mast cell degranulation |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026720 Plant proteins |
| 02/02/2006 | US20060026719 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 02/02/2006 | US20060026716 Transcriptional activators involved in abiotic stress tolerance |
| 02/02/2006 | US20060026707 Isolated from Zea mays; transformed plant; can be used to repress the expression of a desired target gene in specific plant tissue or to prevent the repression of a particular desired target gene |
| 02/02/2006 | US20060026701 Human albumin animal models for drug evaluation, Toxicology and immunogenicity studies |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025580 Novel human estrogen receptor beta |
| 02/02/2006 | US20060025578 Chemical synthesis of reagents for peptide coupling |
| 02/02/2006 | US20060025577 Endothelial cell growth factor methods of isolation and expression |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025574 32 human secreted proteins |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025571 Morphogen-induced dendritic growth |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025565 purified polypeptide and fusion protein for promoting the survival, growth, proliferation, or maintenance of neurons in an injured but not severed spinal cord; axonal regeneration, side effect reduction of scar tissue formation |
| 02/02/2006 | US20060025397 Method of resistance of epilepsy by suppressing the function of alpha 1g protein |
| 02/02/2006 | US20060025367 Adenovirus vectors encoding brain natriuretic peptide |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
| 02/02/2006 | US20060025348 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 02/02/2006 | US20060025344 Ghrelin receptor inverse agonists for regulation of feeding behaviors |
| 02/02/2006 | US20060025343 Angiogenically effective unit dose fo FGF and method of adminstering |
| 02/02/2006 | US20060025341 Isolated polynucleotide encoding inhibin-related proteins for treating cancer of epithelial, testicular, ovarian, prostate; biodrug protein; activin binding activity; hormone inhibitor; muscle regeneration |
| 02/02/2006 | US20060025339 Corticotropin releasing factor 2 receptor agonists |
| 02/02/2006 | US20060025334 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 02/02/2006 | US20060025327 Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent |
| 02/02/2006 | US20060024830 Growth characteristics of filamentous microorganisms |
| 02/02/2006 | US20060024821 Rolling circle replicon expression vector |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024798 Gene knockout; gene overexpression; liposomes |
| 02/02/2006 | US20060024797 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 02/02/2006 | US20060024796 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024794 Novel methods for production of di-chain botulinum toxin |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024790 Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024787 Chimp trace amine associated receptors and polypeptides |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024783 BMP10 propeptides and related methods |
| 02/02/2006 | US20060024780 Isolation; cloning; hybrid anticancer agents; protein genetic mapping of human chromosome |
| 02/02/2006 | US20060024779 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 02/02/2006 | US20060024778 Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptides |
| 02/02/2006 | US20060024777 preparation of non-bitter protein hydrolyzate with defined degree of hydrolysis of 30-33% and an arginine:lysine ratio of at least 5.5:1 from groundnut protein isolate, especially using fungal protease from Aspergillus |
| 02/02/2006 | US20060024766 Bifunctional molecules |
| 02/02/2006 | US20060024761 Protein biopolymer markers predictive of alzheimer's disease |
| 02/02/2006 | US20060024760 Human brain carboxypeptidase B |
| 02/02/2006 | US20060024759 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 02/02/2006 | US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 02/02/2006 | US20060024750 identification of the natural ligand for the orphan G-Protein Coupled Receptor; diagnosis of conditions involving dysregulated receptor activity |
| 02/02/2006 | US20060024748 Cytoxan antibodies and immunoassay |
| 02/02/2006 | US20060024747 Comprises nucleotide sequences coding nitrillase and amidase for transformation and propagation of microorganism capable of catalyzing hydration of certain nitrites to corresponding amides and amides to corresponding carboxylic acids |
| 02/02/2006 | US20060024743 Probes labeled with energy transfer coupled dyes |
| 02/02/2006 | US20060024742 Immunogenic polypeptide of given sequence; diagnosis or treatment of conditions resulting from gene over-expression |
| 02/02/2006 | US20060024739 C. elegans gro-1 gene |
| 02/02/2006 | US20060024730 TF binding compounds |
| 02/02/2006 | US20060024729 Mechanosensitive mammalian potassium channels activatable by polyunsaturated fatty acids and the use of said channels in drug screening |
| 02/02/2006 | US20060024726 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 02/02/2006 | US20060024706 Transforming growth factor beta 1 (TGFbeta1) haplotypes and prediction of susceptibility for immunological disorders |
| 02/02/2006 | US20060024700 determining whether a hepatitis C virus-infected human has an increased risk for developing liver fibrosis, comprising testing nucleic acid from the human for a polymorphism in gene TLR4 as represented by position 101 of SEQ ID NO: 18973 or its complement |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024689 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby |
| 02/02/2006 | US20060024688 Alterations of fibulin genes in macular degeneration |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024670 Influenza virus vaccine composition and methods of use |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024332 Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis |
| 02/02/2006 | US20060024331 Toxin compounds with enhanced membrane translocation characteristics |
| 02/02/2006 | US20060024329 Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2. |
| 02/02/2006 | US20060024324 Glutamate-rich protein (GLURP) genetically coupled to plasmodium falciparum merozoite surface protein 3 (MSP3) for use as tool in preventing malarial infection; Antimalarial agents; parasiticides |
| 02/02/2006 | US20060024323 Active immunization using a siderophore receptor protein |
| 02/02/2006 | US20060024322 Novel prophylactics/remedies for immunopathy |
| 02/02/2006 | US20060024321 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 02/02/2006 | US20060024320 Attenuated pestiviruses |
| 02/02/2006 | US20060024319 determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse; the antibody binds to MNV-1 deposited as American Type Culture Collection (ATCC) Deposit No. PTA-5935 or to a polypeptide encoded by it |
| 02/02/2006 | US20060024316 Prostatic cancer vaccine |
| 02/02/2006 | US20060024310 Methods of treating TNFalpha-mediated tissue injury using anti-TNF antibodies and peptides |
| 02/02/2006 | US20060024305 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 02/02/2006 | US20060024301 Prostate-specific polypeptides and fusion polypeptides thereof |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024296 As an antagonist that inhibits immunoglobulin secretion; autoimmune disorders; antiproliferative , anticarcinogenic and antiarthritic agents; inflammatory bowel disease |
| 02/02/2006 | US20060024291 Protocadherin materials and methods |